Quercetin and its Relative Therapeutic Potential Against COVID-19: A Retrospective Review and Prospective Overview

Author(s): Saiyad Bastaminejad, Salar Bakhtiyari*

Journal Name: Current Molecular Medicine

Volume 21 , Issue 5 , 2021


  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor

Abstract:

COVID-19 is an emerging disease that is a major threat to the global community. The main challenge in this disease is the lack of proper or proven medication. The drugs used to treat this disease are only for symptomatic treatment. Studies of other coronaviruses, such as SARS and MERS, suggest that quercetin has sufficient potential to treat COVID-19. Previous studies have shown that quercetin reduces the entry of the virus into the cell by blocking the ACE2 receptor, as well as reducing the level of interleukin-6 in SARS and MERS patients. Therefore, the aim of this review was to scrutinize the potential of quercetin as a drug in the treatment of COVID-19 from a molecular perspective.

Keywords: Quercetin, therapeutic, COVID-19, ACE2, SARS, MERS.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 21
ISSUE: 5
Year: 2021
Published on: 18 September, 2020
Page: [385 - 391]
Pages: 7
DOI: 10.2174/1566524020999200918150630
Price: $65

Article Metrics

PDF: 29